Skip to main navigation Skip to search Skip to main content

Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 (Blood Cancer Journal, (2022), 12, 9, (137), 10.1038/s41408-022-00736-z)

  • Franck Rapaport
  • , Kenneth Seier
  • , Yaseswini Neelamraju
  • , Duane Hassane
  • , Timour Baslan
  • , Daniel T. Gildea
  • , Samuel Haddox
  • , Tak Lee
  • , H. Moses Murdock
  • , Caroline Sheridan
  • , Alexis Thurmond
  • , Ling Wang
  • , Martin Carroll
  • , Larry D. Cripe
  • , Hugo Fernandez
  • , Christopher E. Mason
  • , Elisabeth Paietta
  • , Gail J. Roboz
  • , Zhuoxin Sun
  • , Martin S. Tallman
  • Yanming Zhang, Mithat Gönen, Ross Levine, Ari M. Melnick, Maria Kleppe, Francine E. Garrett-Bakelman

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 (Blood Cancer Journal, (2022), 12, 9, (137), 10.1038/s41408-022-00736-z)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Mathematics